| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(97)00255-2 |
| P698 | PubMed publication ID | 9221938 |
| P50 | author | William T O'Connor | Q39765198 |
| P2093 | author name string | Lindefors N | |
| Barati S | |||
| P2860 | cites work | Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics | Q28276892 |
| Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses | Q29618915 | ||
| Recent advances in the phencyclidine model of schizophrenia | Q29618917 | ||
| Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks | Q34178907 | ||
| NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. | Q34376965 | ||
| Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia | Q34707093 | ||
| Dopaminergic mechanisms in idiopathic and drug-induced psychoses | Q37920162 | ||
| The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine | Q40576758 | ||
| Evidence of glutamatergic deficiency in schizophrenia | Q41134039 | ||
| Abnormal excitatory neurotransmitter metabolism in schizophrenic brains | Q41670269 | ||
| An N-methylaspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? | Q42204682 | ||
| Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain | Q42500386 | ||
| Fast HPLC Estimation of ?-Aminobutyric Acid in Microdialysis Perfusates: Effect of Nipecotic and 3-Mercaptopropionic Acids | Q42519729 | ||
| Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. | Q44128835 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia | Q46659291 | ||
| Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid | Q48141046 | ||
| Phencyclidine analogues inhibit NMDA-stimulated [3H]GABA release from cultured cortex neurons | Q48183742 | ||
| Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study | Q48191019 | ||
| Excitatory amino acids: implications for psychiatric disorders research | Q48220453 | ||
| Schizophrenics show spatial working memory deficits | Q48400844 | ||
| Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. | Q48687064 | ||
| The receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats | Q48687180 | ||
| Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex. | Q51610553 | ||
| Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines | Q51868136 | ||
| Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
| Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. | Q52069743 | ||
| Cognitive impairment in schizophrenia. | Q52092939 | ||
| The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems | Q67521537 | ||
| Dysfunction in a prefrontal substrate of sustained attention in schizophrenia | Q68819585 | ||
| MK-801 decreases striatal and cortical GAD65 mRNA levels | Q70863180 | ||
| MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors | Q72612635 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | serotonin | Q167934 |
| dopamine | Q170304 | ||
| P304 | page(s) | 205-212 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex | |
| P478 | volume | 759 |
| Q30474638 | 5-HT1A and 5-HT1B receptors differentially modulate rate and timing of auditory responses in the mouse inferior colliculus |
| Q38872263 | A REVIEW OF KETAMINE ABUSE AND DIVERSION. |
| Q39767786 | A heuristic model for working memory deficit in schizophrenia |
| Q37736866 | A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial. |
| Q34157734 | A review of the nonmedical use of ketamine: use, users and consequences |
| Q36606041 | Acute and chronic effects of ketamine upon human memory: a review |
| Q48026745 | Acute ketamine induces hippocampal synaptic depression and spatial memory impairment through dopamine D1/D5 receptors |
| Q44239962 | Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. |
| Q28471824 | An animal model of emotional blunting in schizophrenia |
| Q29617327 | Antidepressant effects of ketamine in depressed patients |
| Q57255770 | Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism |
| Q47828024 | Behavioral and neurochemical changes induced by repetitive combined treatments of ketamine and amphetamine in mice. |
| Q31141730 | Brain imaging in nonhuman primates: insights into drug addiction |
| Q28571490 | Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats |
| Q28482530 | Chronic ketamine administration modulates midbrain dopamine system in mice |
| Q46587017 | Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. |
| Q48436532 | Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. |
| Q43674855 | Delayed stress-induced increase in tissue level of cholecystokinin in rat prefrontal cortex: modulation by microdialysis probe implantation and systemic ketamine |
| Q30492804 | Different serotonin receptor agonists have distinct effects on sound-evoked responses in inferior colliculus |
| Q36124382 | Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801. |
| Q43860040 | Effect of ketamine, dextromethorphan, and MK-801 on cochlear dysfunction induced by transient ischemia |
| Q37279054 | Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters. |
| Q33186255 | Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268. |
| Q43813737 | Effects of ketamine on different types of anxiety/fear and related memory in rats with lesions of the median raphe nucleus |
| Q46764650 | Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose |
| Q90591144 | Effects of monoamine depletion on the ketamine-induced locomotor activity of preweanling, adolescent, and adult rats: Sex and age differences |
| Q30416797 | Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia. |
| Q46367916 | Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. |
| Q46170742 | Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments |
| Q33843027 | Glutamate Deregulation in Ketamine-Induced Psychosis-A Potential Role of PSD95, NMDA Receptor and PMCA Interaction |
| Q38669576 | Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research |
| Q33187534 | Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge |
| Q48264745 | In vivo and ex vivo evidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia |
| Q30413276 | In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T. |
| Q44048911 | Intra- and inter-individual relationships between central and peripheral serotonergic activity in humans: a serial cerebrospinal fluid sampling study. |
| Q37970647 | Intravenous ketamine for treatment-resistant major depressive disorder. |
| Q50497664 | Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects. |
| Q46830813 | Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. |
| Q47380939 | Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling |
| Q26799231 | Legal highs: staying on top of the flood of novel psychoactive substances |
| Q47658882 | Long-Term Ketamine Self-Injections in Major Depressive Disorder: Focus on Tolerance in Ketamine's Antidepressant Response and the Development of Ketamine Addiction |
| Q37307160 | Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants |
| Q89338649 | Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms |
| Q42519594 | NMDA and AMPA/kainate glutamatergic agonists increase the extracellular concentrations of GABA in the prefrontal cortex of the freely moving rat: modulation by endogenous dopamine |
| Q37212699 | Neurochemical modulators of sleep and anesthetic states. |
| Q30368451 | Paliperidone for the treatment of ketamine-induced psychosis: a case report. |
| Q34104228 | Pharmacology and behavioral pharmacology of the mesocortical dopamine system |
| Q43793230 | Phencyclidine-induced dysregulation of dopamine response to amphetamine in prefrontal cortex and striatum |
| Q63433406 | Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems |
| Q43867300 | Prolonged effect of an anesthetic dose of ketamine on behavioral despair |
| Q48308137 | Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. |
| Q43509555 | Rostral ventrolateral medulla suppresses reflex bradycardia by the release of gamma-aminobutyric acid in nucleus tractus solitarii of the rat. |
| Q47549477 | Schizophrenia-Like Dopamine Release Abnormalities in a Mouse Model of NMDA Receptor Hypofunction. |
| Q41430865 | Serotonin in the inferior colliculus fluctuates with behavioral state and environmental stimuli |
| Q37309756 | Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys |
| Q33620630 | Subanesthetic ketamine treatment promotes abnormal interactions between neural subsystems and alters the properties of functional brain networks |
| Q44259214 | Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release |
| Q46296210 | The effects of ketamine on dopaminergic function: meta-analysis and review of the implications for neuropsychiatric disorders |
| Q35200052 | The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use |
| Q37924850 | The in vivo neurochemistry of the brain during general anesthesia |
| Q64105408 | Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System |
| Q40229544 | Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects |
Search more.